Experiments have shown that the inhibition of oxidative stress then regulates TAK1-p38MAPK/NF-κB-NLRP3 pathway activation and that the alleviation of inflammation may be the key mechanism of action against ventricular arrhythmia. The gene discussed is NFKB1; the disease is Ventricular arrhythmia.